Investing

Bristol Myers Squibb : BMY

BMY

Stock Data

$55.57

$1.70 (2.97%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Bristol-Myers Squibb Company is a global biopharmaceutical firm focused on discovering, developing, and delivering innovative medicines for a range of serious diseases. With a rich history dating back to 1887, it specializes in treatments across hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience fields. Its portfolio includes notable drugs like Eliquis, Opdivo, and Sprycel, targeting conditions from cancer to multiple sclerosis. The company markets its products to a variety of clients, including hospitals, pharmacies, and government agencies, aiming to improve patient health outcomes worldwide.

All Bristol Myers Squibb Articles

586 Articles

Alex Sirois | Yesterday

Forget Wall Street’s Ultimate Pharma Value Trap: Here Is a Far Better Stock to Buy Right Now

Bristol Myers Squibb (NYSE:BMY | BMY Price Prediction) is the headline pharma name dividend hunters keep circling, drawn in by…

David Beren | Jun 6, 2026 at 12:11 PM EDT

SCHD’s $85 Billion Strategy Now Concentrates 41 Percent of Your Money in Just Ten Stocks

A 63-year-old retiree with $400,000 parked in the Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) likely picked it for the 100-stock…

John Seetoo | May 28, 2026 at 11:44 AM EDT

SCHD’s $71.6 Billion Portfolio Delivers 20% Gains Plus 3.3% Yield This Year

Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) has become one of the most-owned dividend funds in the country, with $71.6 billion…

David Beren | May 22, 2026 at 12:14 PM EDT

Vanguard’s VIG Quietly Returned 247% While Investors Chased Higher Yields

Retirees evaluating dividend funds tend to anchor on current yield, which is exactly why Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) often…

Michael Williams | May 21, 2026 at 7:30 AM EDT

Why retirees are banking on SCHD’s 15-year unbroken dividend streak

The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) has built its reputation on paying reliable, growing quarterly distributions to income investors,…

Drew Wood | May 10, 2026 at 9:30 AM EDT

A $185,000 Portfolio That Covers Your Groceries, Utilities, and Phone Bill Every Month

The average American household spends about $519 a month on groceries, based on the latest BLS Consumer Expenditure Survey figure…

Drew Wood | May 8, 2026 at 8:29 AM EDT

A $1.5 Million Portfolio That Quietly Pays You $83,400 a Year, No Job Required

An $83,400 annual paycheck sits comfortably above the U.S. median household income of roughly $80,610. Replacing that income with a…

Austin Smith | May 7, 2026 at 5:24 PM EDT

Vanguard High Dividend Yield ETF Delivers 67% Five-Year Returns Against Schwab U.S. Dividend Equity ETF’s Steadier 229% Decade Gain

Schwab U.S. Dividend Equity ETF (NYSEARCA: SCHD) and Vanguard High Dividend Yield ETF (NYSEARCA: VYM) sit on most income investors’…

Vandita Jadeja | May 6, 2026 at 10:32 AM EDT

6 Pharma Dividend Stocks Yielding Up to 6.44% — and They’ve Survived Every Market Crash

Dividend income arrives whether markets rally or sell off. For investors seeking recurring cash flow, high-yield equities remain the cleanest…

Vandita Jadeja | Apr 20, 2026 at 10:50 AM EDT

BMY Stock: Analysts See 16% Upside and a Strong Buy

Bristol-Myers Squibb (NYSE:BMY | BMY Price Prediction) trades at $60.17 as of writing. The 24/7 Wall St. Price Target is…

Michael Williams | Mar 30, 2026 at 9:45 AM EDT

MOAT ETF Is Down 7% in 2026. Here Is the Macro Signal That Changes Everything

VanEck Morningstar Wide Moat ETF (NYSEARCA:MOAT) is down about 7% so far in 2026, yet it has returned roughly 9%…

Michael Williams | Mar 28, 2026 at 7:15 AM EDT

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

VanEck Pharmaceutical ETF (NYSEARCA:PPH) exists to give investors broad exposure to the global pharmaceutical industry without the binary risk of…

Trey Thoelcke | Mar 19, 2026 at 9:10 AM EDT

These 3 Stocks Trigger Bearish Signals but 2 Offer Hidden Opportunity

A death cross forms when a stock’s 50-day moving average crosses below its 200-day moving average, signaling a potential downtrend.…

Lee Jackson | Mar 18, 2026 at 7:19 AM EDT

20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style

After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional perspective on…

Austin Smith | Mar 16, 2026 at 9:00 AM EDT

This Schwab ETF Holds 100 Dividend Stocks, Charges $6 a Year, and Yields More Than Most Savings Accounts

Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) costs $6 a year on a $10,000 investment, holds 100 dividend stocks, and currently…